Michael S. Cuffe - 28 Apr 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and Chief Clinical Officer
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 28 Apr 2023
Transactions value $: -$3,571,396
Form type: 4
Filing time: 02 May 2023, 17:30:01
Previous filing: 26 Apr 2023
Next filing: 02 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Sale	-$3.57M	-12.6K	-30.37%	$284.44	28.8K	28 Apr 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $284.29 to $284.95, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $284.29 to $284.95, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.